PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI, USA.\', \'Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.\', \'Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.\', \'Department of Haematology, Christian Medical College, Vellore, India.\', \'World Federation of Hemophilia, Montreal, QC, Canada.\', \'Department of Infection, Immunity and Cardiovascular disease, University of Sheffield, UK.\', \'Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.\', \'Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.\', \'Coagulation Products Safety Supply and Access Committee of the World Federation of Hemophilia, Montreal, QC, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/hae.14191
?:hasPublicationType
?:journal
  • Haemophilia : the official journal of the World Federation of Hemophilia
is ?:pmid of
?:pmid
?:pmid
  • 33216448
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Management of COVID-19-associated coagulopathy in persons with haemophilia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all